Royal Bank of Canada’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-915,127
Closed -$90.9M 7435
2019
Q3
$90.9M Sell
915,127
-160,865
-15% -$15.3M 0.04% 392
2019
Q2
$99.5M Sell
1,075,992
-98,181
-8% -$9.32M 0.04% 360
2019
Q1
$111M Sell
1,174,173
-286,964
-20% -$25.1M 0.05% 321
2018
Q4
$93.6M Sell
1,461,137
-563,359
-28% -$41.6M 0.05% 344
2018
Q3
$181M Buy
2,024,496
+168,291
+9% +$14.9M 0.08% 222
2018
Q2
$147M Sell
1,856,205
-887,511
-32% -$73.7M 0.07% 245
2018
Q1
$245M Sell
2,743,716
-98,704
-3% -$9.48M 0.11% 161
2017
Q4
$297M Buy
2,842,420
+126,946
+5% +$14.3M 0.13% 140
2017
Q3
$396M Buy
2,715,474
+111,331
+4% +$15.2M 0.19% 98
2017
Q2
$338M Buy
2,604,143
+26,547
+1% +$3.25M 0.17% 109
2017
Q1
$321M Sell
2,577,596
-84,798
-3% -$10.1M 0.17% 104
2016
Q4
$308M Buy
2,662,394
+8,736
+0.3% +$973K 0.17% 104
2016
Q3
$277M Buy
2,653,658
+129,371
+5% +$14M 0.16% 110
2016
Q2
$249M Buy
2,524,287
+298,247
+13% +$30.9M 0.15% 108
2016
Q1
$223M Sell
2,226,040
-112,139
-5% -$11.5M 0.14% 112
2015
Q4
$280M Buy
2,338,179
+1,023,600
+78% +$118M 0.18% 94
2015
Q3
$142M Sell
1,314,579
-35,452
-3% -$4.4M 0.11% 144
2015
Q2
$156M Buy
1,350,031
+4,704
+0.3% +$538K 0.11% 143
2015
Q1
$155M Sell
1,345,327
-508,148
-27% -$60.7M 0.11% 146
2014
Q4
$207M Buy
1,853,475
+243,688
+15% +$25.7M 0.13% 111
2014
Q3
$153M Buy
1,609,787
+421,039
+35% +$38M 0.1% 151
2014
Q2
$102M Buy
1,188,748
+573,166
+93% +$43.6M 0.07% 205
2014
Q1
$43M Sell
615,582
-1,526,388
-71% -$121M 0.03% 407
2013
Q4
$181M Buy
2,141,970
+413,880
+24% +$32.7M 0.13% 121
2013
Q3
$133M Buy
1,728,090
+223,202
+15% +$15.6M 0.1% 136
2013
Q2
$88M Buy
+1,504,888
New +$90.6M 0.07% 191

Other funds holding CELG

Royal Bank of Canada's CELG Position: Q4 2019 in Review

Royal Bank of Canada sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 915,127 shares — an estimated $90.9M sold.

Royal Bank of Canada first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $396M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Royal Bank of Canada reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Royal Bank of Canada sold 915,127 Celgene Corp shares in Q4 2019, an estimated $90.9M.
  • Royal Bank of Canada first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • Royal Bank of Canada's Celgene Corp position peaked at $396M in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Royal Bank of Canada's 13F filing for Q4 2019, filed 14 Feb 2020.